Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Phosphoinositide-3 Kinase Inhibitors
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Phosphoinositide-3 Kinase Inhibitors
Tree Number(s)
D27.505.519.389.736
Unique ID
D000081082
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000081082
Scope Note
Agents that inhibit
PHOSPHOINOSITIDE-3 KINASE
activity.
Entry Term(s)
Phosphoinositide-3 Kinase Inhibitor
Public MeSH Note
2020
History Note
2020
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2020/05/27
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
5-Lipoxygenase-Activating Protein Inhibitors [D27.505.519.389.086]
Acetaldehyde Dehydrogenase Inhibitors [D27.505.519.389.089]
Adenosine Deaminase Inhibitors [D27.505.519.389.092]
Adenylyl Cyclase Inhibitors [D27.505.519.389.108]
Aromatic Amino Acid Decarboxylase Inhibitors [D27.505.519.389.124]
Calcineurin Inhibitors [D27.505.519.389.174]
Carbonic Anhydrase Inhibitors [D27.505.519.389.200]
Catechol O-Methyltransferase Inhibitors [D27.505.519.389.237]
Cholinesterase Inhibitors [D27.505.519.389.275]
Cyclooxygenase Inhibitors [D27.505.519.389.310]
Gamma Secretase Inhibitors and Modulators [D27.505.519.389.315]
Glycoside Hydrolase Inhibitors [D27.505.519.389.320]
Cytochrome P-450 Enzyme Inhibitors [D27.505.519.389.335]
Folic Acid Antagonists [D27.505.519.389.350]
Histone Deacetylase Inhibitors [D27.505.519.389.360]
Hydroxymethylglutaryl-CoA Reductase Inhibitors [D27.505.519.389.370]
Integrase Inhibitors [D27.505.519.389.375]
beta-Lactamase Inhibitors [D27.505.519.389.400]
Lipoxygenase Inhibitors [D27.505.519.389.480]
Monoamine Oxidase Inhibitors [D27.505.519.389.616]
Nucleic Acid Synthesis Inhibitors [D27.505.519.389.675]
Ornithine Decarboxylase Inhibitors [D27.505.519.389.705]
Phosphodiesterase Inhibitors [D27.505.519.389.735]
Phosphoinositide-3 Kinase Inhibitors [D27.505.519.389.736]
Phospholipase A2 Inhibitors [D27.505.519.389.737]
Poly(ADP-ribose) Polymerase Inhibitors [D27.505.519.389.739]
Prolyl-Hydroxylase Inhibitors [D27.505.519.389.740]
Protease Inhibitors [D27.505.519.389.745]
Protein Kinase Inhibitors [D27.505.519.389.755]
Protein Synthesis Inhibitors [D27.505.519.389.760]
Proton Pump Inhibitors [D27.505.519.389.848]
Steroid Synthesis Inhibitors [D27.505.519.389.870]
Topoisomerase Inhibitors [D27.505.519.389.892]
Uncoupling Agents [D27.505.519.389.936]
Expand All
Collapse All
Phosphoinositide-3 Kinase Inhibitors
Preferred
Concept UI
M000649677
Scope Note
Agents that inhibit
PHOSPHOINOSITIDE-3 KINASE
activity.
Terms
Phosphoinositide-3 Kinase Inhibitors
Preferred Term
Term UI
T000957708
Date
05/13/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
Phosphoinositide-3 Kinase Inhibitor
Term UI
T000998976
Date
11/21/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
page delivered in 0.162s
